Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Minzhao Lin"'
Autor:
Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li, Huihai Zhong, Tan Li, Zecong Xiao, Yong Wang, Xintao Shuai
Publikováno v:
Aggregate, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract Nanodrugs capable of aggregating in the tumor microenvironment (TME) have demonstrated great efficiency in improving the therapeutic outcome. Among various approaches, the strategy utilizing electrostatic interaction as a driving force to ac
Externí odkaz:
https://doaj.org/article/0026e649f0024bf1a63cb790aaafe622
Autor:
Bo Li, Yuejun Lin, Gengjia Chen, Mingyue Cai, Huihai Zhong, Zecong Xiao, Minzhao Lin, Tan Li, Yujun Cai, Xintao Shuai, Jie Ren
Publikováno v:
Advanced Science, Vol 10, Iss 33, Pp n/a-n/a (2023)
Abstract The protective blood‐brain barrier (BBB) prevents most therapeutic agents from entering the brain. Currently, focused ultrasound (FUS) is mostly employed to create microbubbles that induce a cavitation effect to open the BBB. However, micr
Externí odkaz:
https://doaj.org/article/b61c6a14d7a44d8babf85f8d2774c836
Publikováno v:
Science China Chemistry. 65:1383-1400
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::396956cb9e3c176990e352c69383e4d7
https://doi.org/10.1007/s11426-022-1262-x
https://doi.org/10.1007/s11426-022-1262-x
Autor:
Huihai Zhong, Gengjia Chen, Tan Li, Jinsheng Huang, Minzhao Lin, Bo Li, Zecong Xiao, Xintao Shuai
Publikováno v:
Nano Letters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc6bd43d90df91c367724d507d2f61e
https://doi.org/10.1021/acs.nanolett.3c01008
https://doi.org/10.1021/acs.nanolett.3c01008
Autor:
TianCheng Wang, MinZhao Lin, JunJie Mao, LiRong Tian, HaiRun Gan, XinYan Hu, LeYe Yan, HaoYu Long, JianXun Cai, XiaoDi Zheng, YuDong Xiao, Dan Li, XinTao Shuai, PengFei Pang
Publikováno v:
ACS applied materialsinterfaces.
Immune checkpoint blockade (ICB) utilizing programmed death ligand-1 (PD-L1) antibody is a promising treatment strategy in solid tumors. However, in fact, more than half of hepatocellular carcinoma (HCC) patients are unresponsive to PD-L1-based ICB t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9079ae56fec80eec07c40938a61804da
https://pubmed.ncbi.nlm.nih.gov/36314479
https://pubmed.ncbi.nlm.nih.gov/36314479
Autor:
Jinsheng Huang, Huiling Huang, Yiyao Wang, Bin Xu, Minzhao Lin, Shisong Han, Yuanyuan Yuan, Yong Wang, Xintao Shuai
Publikováno v:
Biomaterials. 299:122134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f965630c1d81e0180f3d5cd46d7d481
https://doi.org/10.1016/j.biomaterials.2023.122134
https://doi.org/10.1016/j.biomaterials.2023.122134
Autor:
Lijun Hu, Sicong Huang, Gengjia Chen, Bo Li, Tan Li, Minzhao Lin, Yongquan Huang, Zecong Xiao, Xintao Shuai, Zhongzhen Su
Publikováno v:
ACS applied materialsinterfaces. 14(28)
Oxaliplatin (OXA) is a first-line chemotherapeutic agent for treating colorectal cancer (CC). However, the chemotherapeutic effect of OXA on CC is limited by the M2-like polarization of tumor-associated macrophages (TAMs) in the tumor microenvironmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::600e1912349383d419f7ce7186ff6d7a
https://pubmed.ncbi.nlm.nih.gov/35796429
https://pubmed.ncbi.nlm.nih.gov/35796429
Publikováno v:
Biomaterials. 296:122067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e724db64c57ac3b65995fbc418bccde
https://doi.org/10.1016/j.biomaterials.2023.122067
https://doi.org/10.1016/j.biomaterials.2023.122067
Autor:
Tan Li, Gengjia Chen, Zecong Xiao, Bo Li, Huihai Zhong, Minzhao Lin, Yujun Cai, Jing Huang, Xi Xie, Xintao Shuai
Publikováno v:
Nano letters. 22(7)
Recent breakthroughs in cell membrane-fabricated nanovaccine offer innovateive therapeutic options for preventing tumor metastasies and recurrence, yet the treatment of patient-specific solid tumor remained challenging owing to the immunosuppressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00fe2a341fbd3d7f43492a54935cd4b
https://pubmed.ncbi.nlm.nih.gov/35357839
https://pubmed.ncbi.nlm.nih.gov/35357839
Autor:
Lihua Du, Haozhe He, Zecong Xiao, Hong Xiao, Yongcheng An, Huihai Zhong, Minzhao Lin, Xiaochun Meng, Shisong Han, Xintao Shuai
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 18(15)
Immunotherapy brings great benefits for tumor therapy in clinical treatments but encounters the severe challenge of low response rate mainly because of the immunosuppressive tumor microenvironment. Multifunctional nanoplatforms integrating effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f64f2e08b45a53d0bfb4417ceb7f645
https://pubmed.ncbi.nlm.nih.gov/35218310
https://pubmed.ncbi.nlm.nih.gov/35218310